SHARPE
Reported results
- Third quarter reported revenue of $1,692.5 million, up 10% compared to $1,544.9 million in Q3 2025; local currency revenue growth of 9%
- GAAP diluted EPS of $1.79 per share in Q3 2026, up 39% from $1.29 per share in Q3 2025
- Non-GAAP adjusted diluted EPS attributable to Equifax of $2.26 per share in Q3 2026, up 11% from $2.04 per share in Q3 2025
- Non-GAAP adjusted EBITDA margin of 33.1% in Q3 2026 compared to 32.7% in Q3 2025
- GAAP net income attributable to Equifax of $211.7 million in Q3 2026, up 32% from $160.2 million in Q3 2025
- Company returned $158 million in cash to shareholders through $92 million in share repurchases and $66 million in quarterly dividends
Guidance
- Full year 2026 reported revenue guidance: $6.646 billion to $6.676 billion (at midpoint $6.661 billion)
- Full year 2026 reported revenue growth guidance: 9.4% to 9.9% (low-end to high-end)
- Full year 2026 local currency revenue growth guidance: 8.5% to 9.0%
- Full year 2026 organic local currency revenue growth guidance: 8.4% to 8.9%
- Full year 2026 adjusted EPS guidance: $8.45 to $8.55 per share (at midpoint $8.50 per share)
- Q4 2026 reported revenue guidance: $1.605 billion to $1.635 billion
- Q4 2026 reported revenue growth guidance: 3.5% to 5.4%
- Q4 2026 adjusted EPS guidance: $2.07 to $2.17 per share
Notes
The company reduced its full year 2026 revenue guidance at the midpoint to $6.661 billion and adjusted EPS guidance at the midpoint to $8.50 per share (a reduction of only $0.04 per share), citing a much weaker U.S. mortgage market in the latter half of Q3 2026 that is expected to continue through the remainder of 2026. The company maintains its Diversified Markets revenue guidance for high single-digit percent growth. Círculo de Crédito acquisition expected to close in Q4 2026.
Price and volatility reaction
The stock moved +11.3% on the print. No front-expiry chain was on file, so there is no straddle expected move. 30-day ATM implied volatility moved -7.5 vol points across the event (constant-maturity series — not the front-week crush).
| Measure | Value | Basis |
|---|---|---|
| Close before release | 158.57 | 2026-10-19 |
| Close after release | 176.54 | 2026-10-20 |
| Realised move | +11.3% | close to close |
| 30d ATM IV change | -7.5 vol pts | constant-maturity series, not the front expiry |
Source
The figures above come from the earnings release the company filed with the SEC on 2026-10-20 (8-K, Item 2.02). Read the original filing on sec.gov.